Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy W Jones

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Dementia and Geriatric Cognitive Disorders Extra|April 9, 2014
Caregiver Burden in Alzheimer's Disease: Differential Associations in Adult-Child and Spousal Caregivers in the GERAS Observational StudyCatherine Reed, Mark Belger, Grazia Dell'agnello, et al.
Health and Quality of Life Outcomes|January 23, 2017
How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer's disease?Catherine Reed, Annabel Barrett, Jeremie Lebrec, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 5, 2018
Determinants of time to institutionalisation and related healthcare and societal costs in a community-based cohort of patients with Alzheimer's disease dementiaMark Belger, Josep Maria Haro, Catherine Reed, et al.
Dementia and Geriatric Cognitive Disorders|September 30, 2009
Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's diseaseDavid Wilkinson, Rachel Schindler, Elias Schwam, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 8, 2015
Determinants of societal costs in Alzheimer's disease: GERAS study baseline resultsRichard Dodel, Mark Belger, Catherine Reed, et al.
Journal of Alzheimer'S Disease : JAD|March 18, 2017
What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS StudyCatherine Reed, Michael Happich, Josep Maria Argimon, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2018
Psychological and Mnemonic Benefits of Nostalgia for People with DementiaSanda Ismail, Gary Christopher, Emily Dodd, et al.
International Journal of Geriatric Psychiatry|February 7, 2022
Limited receipt of support services among people with mild-to-moderate dementia: Findings from the IDEAL cohortJayden O van Horik, Rachel Collins, Anthony Martyr, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2017
Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's diseaseAnders Gustavsson, Colin Green, Roy W Jones, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 18, 2008
The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristicsRoy W Jones, Miia Kivipelto, Howard Feldman, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Dementia and Geriatric Cognitive Disorders Extra|April 9, 2014
Caregiver Burden in Alzheimer's Disease: Differential Associations in Adult-Child and Spousal Caregivers in the GERAS Observational StudyCatherine Reed, Mark Belger, Grazia Dell'agnello, et al.
Health and Quality of Life Outcomes|January 23, 2017
How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer's disease?Catherine Reed, Annabel Barrett, Jeremie Lebrec, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 5, 2018
Determinants of time to institutionalisation and related healthcare and societal costs in a community-based cohort of patients with Alzheimer's disease dementiaMark Belger, Josep Maria Haro, Catherine Reed, et al.
Dementia and Geriatric Cognitive Disorders|September 30, 2009
Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's diseaseDavid Wilkinson, Rachel Schindler, Elias Schwam, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 8, 2015
Determinants of societal costs in Alzheimer's disease: GERAS study baseline resultsRichard Dodel, Mark Belger, Catherine Reed, et al.
Journal of Alzheimer'S Disease : JAD|March 18, 2017
What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS StudyCatherine Reed, Michael Happich, Josep Maria Argimon, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2018
Psychological and Mnemonic Benefits of Nostalgia for People with DementiaSanda Ismail, Gary Christopher, Emily Dodd, et al.
International Journal of Geriatric Psychiatry|February 7, 2022
Limited receipt of support services among people with mild-to-moderate dementia: Findings from the IDEAL cohortJayden O van Horik, Rachel Collins, Anthony Martyr, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2017
Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's diseaseAnders Gustavsson, Colin Green, Roy W Jones, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 18, 2008
The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristicsRoy W Jones, Miia Kivipelto, Howard Feldman, et al.
Pageof 9